Boudreau Philip P 4
4 · ABBOTT LABORATORIES · Filed Feb 23, 2024
Insider Transaction Report
Form 4
Boudreau Philip P
EVP AND CFO
Transactions
- Award
Common shares without par value
2024-02-21+23,024→ 41,091 total - Award
Option (right to buy)
2024-02-21+86,519→ 86,519 totalExercise: $116.98From: 2025-02-21Exp: 2034-02-20→ Common Shares (86,519 underlying)
Holdings
- 353(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2024.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 28,839 on February 21, 2025, 28,840 on February 21, 2026, and 28,840 on February 21, 2027.